Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24230CH2016PTC041139 Incorporated 20 July 2016 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹6.59 Cr
▲ 3% YoY
Net profit · FY 2025
₹12.56 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹23.5 Lakh
EBITDA margin 3.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered

About Kryptomed Formulations Private Limited

Data last updated:

Kryptomed Formulations Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2016PTC041139. Its GSTIN is 06AAGCK2346A1Z1 (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kirti Mehta and Anshul Madan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO 827 Second Floor Nac Manimajra Chandigarh, Chandigarh, India – 160101.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.59 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹12.56 Lakh (net margin 1.9%) and EBITDA of ₹23.5 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 17% over five years.

Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.

Kryptomed Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0005799). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kryptomed.com.

Company Details of Kryptomed Formulations Private Limited
CIN U24230CH2016PTC041139
Registration Number 041139
Incorporation Date 20 July 2016
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0005799
Key People
Kirti Mehta Director Anshul Madan Director Vipin Kumar Director

Recognitions & Rankings of Kryptomed Formulations

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-13-0005799
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    kryptomed.com
  • Social Media
    Locked
  • Registered Address
    SCO 827 Second Floor Nac Manimajra Chandigarh, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Kryptomed Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Kryptomed Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kryptomed Formulations Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Kryptomed Formulations Private Limited

The main business activity of Kryptomed Formulations is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Kryptomed Formulations Private Limited FY 2024 filings available

Kryptomed Formulations Private Limited reported revenue of ₹6.59 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹6.59 Cr ▲ 3%
Net profit · FY 2025
₹12.56 Lakh margin 1.9%
EBITDA · FY 2025
₹23.5 Lakh margin 3.6%

Compounded Annual Growth Rate (CAGR) of Kryptomed Formulations Private Limited

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 11%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 20%
5 years · compounded
▲ 24%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 3% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Kryptomed Formulations Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹23.5 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹12.56 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Kryptomed Formulations Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.6%••••••••••••••••
Net Profit Margin1.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kryptomed Formulations are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Kryptomed Formulations Private Limited

Kryptomed Formulations has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Kirti MehtaDirector20 Jul 201610 Years 3 MonthsCurrent
Anshul Madan
Also directs: LKM Remedies Private Limited, Shagun Medi Testing Private Limited
Director20 Jul 201610 Years 3 MonthsCurrent
Vipin KumarDirector20 Jul 201610 Years 3 MonthsCurrent
View all directors

Peer Comparison of Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fedley Healthcare Private Limited₹6.61 Cr (FY 2024)••••••••-6.0%••••Raipur Rani, Haryana, India
Winy Healthcare Private Limited₹6.6 Cr (FY 2024)••••••••17.0%••••Agra, Uttar Pradesh, India
Affigenix Biosolutions Private Limited₹6.6 Cr (FY 2025)••••••••105.0%••••Chennai, Tamil Nadu, India
Water Dna Private Limited₹6.6 Cr (FY 2022)••••••••27.0%••••Chennai, Tamil Nadu, India
Darius Healthcare and Management Services Private Limited₹6.59 Cr (FY 2024)••••••••137.0%••••Bangalore, Karnataka, India
Kryptomed Formulations Private Limited this company₹6.59 Cr (FY 2025)••••••••3.0%••••Chandigarh, India
Indu Formulations Private Limited₹6.58 Cr (FY 2017)••••••••12.0%••••Hyderabad, Telangana, India
Phytovedic (India) Private Limited₹6.58 Cr (FY 2025)••••••••-5.0%••••Mumbai, Maharashtra, India
Menamed Pharma Private Limited₹6.58 Cr (FY 2025)••••••••26.0%••••Delhi, India
Strump Lab Private Limited₹6.57 Cr (FY 2025)••••••••6.0%••••New Delhi, Delhi, India
Orchid Medicare Private Limited₹6.57 Cr (FY 2024)••••••••-52.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Kryptomed Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited is audited by AMIT BAJAJ & ASSOCIATES for the financial year 2024.

NameStatusAppointment DateCessation Date
AMIT BAJAJ & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Kryptomed Formulations Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.

MSME Payment Delays by Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 28 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (3 of 3)

SupplierAmount dueDue sinceReported on
an individual supplier••••••••••••
Ultra Drugs Private Limited••••••••••••
Merx Healthcare Communications Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Kryptomed Formulations Private Limited

Employment history and EPFO contributions of people linked to Kryptomed Formulations.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Kryptomed Formulations Private Limited

Kryptomed Formulations Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Anshul Madan was appointed as Director on 20 Jul 2016.

AGM
Kryptomed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Kryptomed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Appointed
Anshul Madan was appointed as Director.
Appointed
Kirti Mehta was appointed as Director.
Appointed
Vipin Kumar was appointed as Director.
Incorporation
20 Jul 2016
Kryptomed Formulations Private Limited was registered on 20 Jul 2016 with Roc Chandigarh & aged 10 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Kryptomed Formulations Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kryptomed Formulations Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Kryptomed Formulations Private Limited

Kryptomed Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AAGCK2346A1Z1HaryanaActive29 Mar 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kryptomed Formulations Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kryptomed Formulations Private Limited

Kryptomed Formulations is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2016 (10+ years old) and is registered under CIN U24230CH2016PTC041139.

Kryptomed Formulations reported revenue of ₹6.59 Cr for FY 2025 (up 3% YoY).

Kryptomed Formulations has 3 current directors:

Kryptomed Formulations reported a net profit of ₹12.56 Lakh (net margin 1.9%) and EBITDA of ₹23.5 Lakh (EBITDA margin 3.6%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Kryptomed Formulations is 11% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Kryptomed Formulations is 06AAGCK2346A1Z1, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Kryptomed Formulations is U24230CH2016PTC041139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kryptomed Formulations has 2 court cases on record: 2 filed by the company. 2 are pending.

Kryptomed Formulations was incorporated on 20 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Kryptomed Formulations by revenue are Fedley Healthcare Private Limited, Winy Healthcare Private Limited, Affigenix Biosolutions Private Limited, Water Dna Private Limited, Darius Healthcare and Management Services Private Limited and 5 more, all in the Pharma industry (Formulations).

Anshul Madan was appointed as Director on 20 Jul 2016. Kirti Mehta was appointed as Director on 20 Jul 2016. Vipin Kumar was appointed as Director on 20 Jul 2016.

Yes, Kryptomed Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0005799).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available